Fenbendazole is an antiparasitic drug that has a long history of use in treating parasitic infections in laboratory animals, livestock and companion animals. It is also well tolerated in humans.
It was used in a sanare lab cancer treatment protocol by Joe Tippens and others and has been reported to prevent cancer growth, tumor progression and overcome chemotherapy resistance. It is believed to act by inhibiting cell proliferation, blocking the action of certain enzymes and suppressing cellular metabolism.
In addition, sanare lab fenbendazole may prevent metastasis and help reduce the toxicity of other therapies.
The scientists at Johns Hopkins discovered fenbendazole stopped glioblastoma tumors from growing on some mice in their laboratory. Then they figured out that it could be used in conjunction with other tumor treatments to make the effects stronger.
Initially, it was thought that sanare lab fenbendazole worked by killing off the cells that were causing the glioblastoma tumors to grow. But later research found that fenbendazole actually blocked tumors from developing by stopping the cells from dividing.
Fenbendazole (also known as Panacur) is a broad spectrum benzimidazole class anthelmintic drug. It is used to treat gastrointestinal parasites such as roundworms, giardiasis, hookworms, whipworms and pinworms (enterobiasis, oxyuriasis). It is also widely used to control parasitic diseases in other animals and livestock. It is also very effective in killing tapeworms.